Stephen L. Hurst - Director, Former Director at Definium Therapeutics, Inc.

Issuer-level insider activity

Role: Director, Former Director
Issuer ticker: DFTX on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Stephen L. Hurst since 13 Sep 2025

Reported holdings for Stephen L. Hurst in Definium Therapeutics, Inc.

Form 4 holding Director, Former Director

Mind Medicine (MindMed) Inc.

Security class: Subordinate Voting Shares
Shares / value: 39,000,000
Estimated value: $45,630,000
Report date: 01 Jan 2022
Price: $1.17
Ownership: By Savant Addiction Medicine, LLC

Form 4 holding Director, Former Director

Mind Medicine (MindMed) Inc.

Security class: Subordinate Voting Shares
Shares / value: 1,722,678
Estimated value: $2,015,533
Report date: 01 Jan 2022
Price: $1.17
Ownership: By Sunray Asset Management

Form 4 holding Director, Former Director

Mind Medicine (MindMed) Inc.

Security class: Subordinate Voting Shares
Shares / value: 100
Estimated value: $117
Report date: 01 Jan 2022
Price: $1.17
Ownership: Direct

Transaction history for Stephen L. Hurst in Definium Therapeutics, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .